Tag: $5.4bn deal
Pfizer to buy Global Blood Therapeutics in $5.4bn cash deal
United States pharmaceutical maker, Pfizer, and biopharmaceutical company, Global Blood Therapeutics (GBT), on Monday, agreed that Pfizer would acquire GBT in an all-cash deal...